Elsbernd Brian

Chief Compliance/Legal OfficerCATALYST PHARMACEUTICALS, INC. (CPRX) · full profile →Form 4 · filed Sep 5, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$987K
Net Open-Market Flow
-$987K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 4, 2025Sell(S)30K$19.52$586K189K
Sep 4, 2025Option exercise(M)30K$2.24$67K219K
Sep 3, 2025Option exercise(M)20K$2.24$45K209K
Sep 3, 2025Sell(S)20K$20.08$402K189K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 4, 2025Option exercise(M)30K$0959K
Sep 3, 2025Option exercise(M)20K$0989K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001161697-25-000318) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.